Profiel
Leonard Scott Dove is a former Director-Compound Partnering at Pharmaceutical Product Development LLC.
He was also an Executive Director-Clinical Development at Allergan Ltd. (Ireland) from 2015 to 2017.
From 2017 to 2022, he served as the Senior Vice President & General Manager at PPD, Inc. Most recently, in 2022, he held the position of Chief Operating Officer at Aravive, Inc. Dr. Dove obtained his undergraduate and doctorate degrees from Texas A&M University.
Eerdere bekende functies van Leonard Dove
| Bedrijven | Functie | Einde |
|---|---|---|
| ARAVIVE, INC. | Operationeel Directeur | 01-08-2023 |
| PPD, INC. | Corporate Officer/Principal | 01-03-2022 |
| ALLERGAN PLC | Hoofd Techniek/Wetenschap/O&O | 01-11-2017 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Corporate Officer/Principal | - |
Opleiding van Leonard Dove
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
PPD, Inc.
PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
















